Ascites is an early and common complication of decompensated cirrhosis. The FDA approval of the Alfapump system presents a new option for treating ascites, providing a different option to improve quality of life for patients with cirrhosis. In this interview, Drs. Jasmohan Baja and Catherine Lucero discuss the optimal criteria for patient selection, perioperative and postoperative complications, the impact of quality of life and long-term outcomes for incorporating this new option into clinical practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Top 6 courses
-

-

-

-

-

-
Guideline Update: PSVD-NCPF Nomenclature0.5 Credits
Specialties served/covered
- Adolescent Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Interventional Radiology
- Medical Oncology
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Transplant Hepatology
- Radiation Oncology
- Surgical Oncology
- Transplant Hepatology
- Cross-Specialty
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- No reviews yet. Be the first to share yours.


